《半日總結》恆指跌172點 內房股挫 聯想集團彈逾6%
烏克蘭局勢升溫,港股早市隨亞太區股市下跌。恆指低開218點後窄幅爭持,跌幅曾收窄至96點見24,231點,半日跌172點或0.71%,報24,155點;國指跌71點或0.84%,報8,466點;恆生科技指數跌76點或1.4%,報5,402點。大市半日成交總額680億元。滬、深港通南下交易半日分別淨流入14.42億及21.74億元人民幣。
正榮地產(06158.HK)或未能如期還債,向永續證券持有人尋求豁免及修訂,股價挫12.6%。其他內房股受壓。融創(01918.HK)跌10.4%,合景泰富(01813.HK)跌6%,世茂(00813.HK)、雅居樂(03383.HK)及奧園(03883.HK)各跌4.9%至5.5%。龍湖(00960.HK)、潤地(01109.HK)及恆大(03333.HK)各跌3%至3.2%。物管股恆大物業(06666.HK)將被剔出國指成分股,股價跌4.3%。
科技股方面,美團(03690.HK)低開逾5%後曾倒升,半日跌1.1%報185.9元,阿裏巴巴(09988.HK)跌3.2%報115.7元,騰訊(00700.HK)跌2.8%報457元,百度(09888.HK)、嗶哩嗶哩(09626.HK)及快手(01024.HK)各跌3%至3.5%。京東健康(06618.HK)跌6.6%。
將被剔出恆生科技指數的微盟(02013.HK)及汽車之家(02518.HK)各跌6.8%及4.9%,同程旅行(00780.HK)跌3.3%,將被納入該指數的商湯(00020.HK)升8.1%,理想汽車(02015.HK)及小鵬汽車(09868.HK)分別升0.4%及跌2.5%。
聯想集團(00992.HK)及農夫山泉(09633.HK)染藍,聯想集團(00992.HK)升6.6%報9.1元,農夫山泉(09633.HK)倒跌0.3%報47.75元。落選熱門中國飛鶴(06186.HK)跌2.4%。
康希諾生物(06185.HK)重組新冠病毒疫苗獲批用於序貫加強免疫接種,該股高開近9%升幅收窄,半日升2.5%報144.1元。其他醫藥股方面,信達生物(01801.HK)及翰森製藥(03692.HK)各跌2.6%及4.4%,石四藥(02005.HK)升2.7%。
俄鋁(00486.HK)跌6.4%報7.86元。國際金融股方面,匯控(00005.HK)平收報58元,渣打(02888.HK)升3.4%報61.2元,友邦(01299.HK)跌0.3%報87.7元。其他藍籌方面,海底撈(06862.HK)料去年盈轉虧,最多蝕約45億人幣,早市股價跌3.1%報19.58元。
港交所(00388.HK)跌0.7%報431元。濠賭股銀娛(00027.HK)及金沙中國(01928.HK)各跌2.4%及2.5%,本港地產股恆地(00012.HK)跌2.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.